Abstract:BACKGROUND: An intricate interplay between innate and adaptive immune cells is crucial for an effective immune response during disease, infection and vaccination. This interplay is mainly performed by dendritic cells (DCs), which are professional antigen presenting cells with unparalleled capacity to translate innate to adaptive immunity. They effectively recognize and uptake antigens, migrate to lymphoid tissues, and activate naïve T-cells. Indeed, DCs have numerous germline encoded pattern recognition receptors (PRR) that recognize conserved pathogen associated molecular patterns (PAMPs) or danger associated molecular patterns (DAMPs). While some PRRs like Toll-like receptors (TLRs) recognize PAMPs and DAMPs at the cell surface and in endosomal/lysosomal compartments, others, such as NOD-like receptors (NLRs), act as cytosolic sensors. NLRs activation through recognition of PAMPs and DAMPs leads to the assembly of signaling multimeric protein complexes named inflammasomes. Inflammasomes are important regulators of caspase 1, the enzyme responsible for the proteolytically cleavage of precursors' pro-IL-1β and pro-IL-18 into their active form.OBJECTIVE: To unveil how inflammasomes are related to maturation, migration, antigen presenting function and DCs ability to fine tune adaptive immune responses.CONCLUSION: Several studies show that in danger/infectious scenarios NLR and TLR synergize to expand DCs maturation, migration, antigen presenting function and adaptive immune system activation. However, in the absence of a danger scenario, and without TLR engagement, inflammasome activation stimulates an immunosuppressive profile on DCs. Overall, it is clear from literature that activation of the inflammasome in DCs should not be viewed in isolation but rather considering its interconnections with the various PPRdriven pathways. Due to the increasing evidences of inflammasome involvement in multiple inflammatory and immune diseases, this information is of utmost importance since precise inflammasome pharmacological targeting could lead to considerable clinical utility through fine-tuned targeted therapies.

Traditional approaches and recent tools for studying inflammasome activity

Activation and Pharmacological Regulation of Inflammasomes

Inflammasomes: mechanism of action, role in disease, and therapeutics

Inflammasome activation: from molecular mechanisms to autoinflammation

Inflammasomes: Mechanisms of Action and Involvement in Human Diseases

Inflammasomes as therapeutic targets in human diseases

Techniques to Study Inflammasome Activation and Inhibition by Small Molecules

The role of inflammasomes in human diseases and their potential as therapeutic targets

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

Inflammasomes and their roles in health and disease

A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases

[Research advances of inflammasome and its role in sepsis].

Updating the NLRC4 Inflammasome: from Bacterial Infections to Autoimmunity and Cancer

Inflammasomes in Inflammation-Induced Cancer

Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis

Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies

Inflammasome as a promising therapeutic target for cancer

Emerging Concepts about NAIP/NLRC4 Inflammasomes

Noncanonical inflammasomes: Antimicrobial defense that does not play by the rules

How Inflammasomes Inform Adaptive Immunity

Structures and functions of the inflammasome engine